Author Information
Matej Orešič is a prominent researcher affiliated with multiple esteemed institutions, including the Turku Centre for Biotechnology at the University of Turku and Åbo Akademi University in Finland, the Steno Diabetes Center A/S in Denmark, and the VTT Technical Research Centre of Finland. His multidisciplinary work spans various aspects of biotechnology and related fields, reflecting his diverse expertise and leadership in the scientific community.Research Contributions
Matej Orešič has made significant contributions to the field of biotechnology, particularly in areas related to metabolic health, lipidomics, and neurodegenerative disorders. Some of his recent work in 2022 includes research on bisulfite sequencing data analysis, the impact of frailty on outcomes after traumatic brain injury, and plasma lipid alterations in young adults with psychotic experiences. His research also delves into the glycomic and glycoproteomic techniques in neurodegenerative disorders and the progression of non-alcoholic fatty liver disease, highlighting his focus on personalized medicine and diagnostic markers.Aliases
Throughout his career, Matej Orešič has published under various aliases, including Matej Orešic, Matija Orešić, Matej Oresčic, M Oresic, and M. Orešić, among others. These aliases reflect the different transliterations and variations of his name across different publications and platforms.Publication and Citation Metrics
| Metric |
Value |
| Citation Count |
31,237 |
| h-index |
87 |
| Paper Count |
446 |
